Physician profile

Bruce A Phillips

Family Medicine · Plainville, MA

NPI 1437161973

$739.05

in general payments reported to CMS, 2019-2025

17 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Glaxosmithkline, LLC. $150.11 2019
Janssen Pharmaceuticals, INC $79.54 2019-2020
Astrazeneca Pharmaceuticals LP $79.54 2019-2020
Pfizer INC. $58.29 2019-2021
Abbott Laboratories $41.34 2019-2022
Astellas Pharma US INC $37.90 2019
Merck Sharp & Dohme LLC $37.54 2019-2020
E.R. Squibb & Sons, L.L.C. $34.91 2019
Abbvie INC. $30.24 2019-2022
Boehringer Ingelheim Pharmaceuticals, INC. $30.23 2019-2020
Allergan, INC. $28.29 2019
Sanofi Pasteur INC. $27.24 2021
Lilly USA, LLC $22.85 2019
Amarin Pharma, INC. $22.84 2020
Novo Nordisk INC $22.45 2019
Show all 17 companies
CompanyGeneral paymentsYearsTop products
Amgen INC. $21.48 2019
Teva Pharmaceuticals USA, INC. $14.26 2020

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Bruce A Phillips

$739.05

in general payments reported 2019-2025

Years
2019-2022
Top company
Glaxosmithkline, LLC.

https://glasscript.com/doctor/64293/bruce-a-phillips

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.